August 1, 2017Open Access

Recent developments in age-related macular degeneration: a review

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Identification of modifiable risk factors would improve the possibilities of preventing the progression of AMD. The role of anti-vascular endothelial growth factor (anti-VEGF) agents has transformed the therapeutic approach of the potentially blinding disease "wet AMD" into a more favorable outcome.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Al-Zamil et al. (Tue,) studied this question.

synapsesocial.com/papers/696a57eb41d3e7e88fb2e1c9 https://doi.org/https://doi.org/10.2147/cia.s143508

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1CLINICOPATHOLOGIC CORRELATION OF DRUSEN AND RETINAL PIGMENT EPITHELIAL ABNORMALITIES IN AGE-RELATED MACULAR DEGENERATION1994 · 197 citations
2Distribution of fundus autofluorescence with a scanning laser ophthalmoscope.1995 · 523 citations
3VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION2004 · 473 citations
4Age-Related Macular Degeneration2008 · 1,350 citations
5Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration: how to alleviate the clinical burden with maintained functional results2014 · 43 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo